Episode 39: Building a Robust Startup Unit in Clinical Trials

Episode 40: Leading from the Ground Up: Strategy, Transition, and Team Accountability

In this episode, Global Head of Clinical Trial Delivery Diane Leclerc explores how ground‑level insight shapes strategy, accelerates decisions, and strengthens team accountability. She unpacks practical ways organizations can empower operational teams to influence direction, innovate, and adapt during leadership transitions. Through real examples from clinical research, Diane highlights how local expertise drives expansion success, why emergent strategies matter, and how proactive risk management builds trust across sites, sponsors, and patients. Listeners will gain actionable guidance on building resilient teams, navigating change, and sustaining operational excellence in fast‑moving environments.

Episode 39: Building a Robust Startup Unit in Clinical Trials

In this episode, Esther Sanchez, Associate Director of the Global Start-Up Unit at Indero, shares insights from her 24+ years in clinical research. She breaks down why a strong startup unit is critical to clinical trial success, how resilient “front‑line” teams protect timelines, and the essential checks every company should implement to avoid costly delays. Esther also highlights common challenges in regulatory submissions, site activation, and cross-functional alignment, offering practical strategies to strengthen collaboration, accountability, and risk management. Tune in for actionable guidance to improve startup efficiency and elevate trial outcomes.

Episode 38: Eczema, Equity, and Empowerment

In this episode of Phase Forward, Raelle Kennedy Brown—brand marketing consultant, patient advocate, and founder of Woke Within (Skin), shares how storytelling can transform patient advocacy. We discuss building trust in clinical trials, designing research that reflects diversity, and addressing the unique challenges faced by patients with eczema, especially those with melanated skin. Raelle’s insights reveal why inclusive representation and patient voices are essential to improving care.

Episode 37: ISF: A New Dimension in Skin Biomarkers

This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and Théo Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate the potential of ISF sampling, paving the way for more personalized and innovative approaches to care.

Episode 36: Clinical Trials Across Asia

In this episode of Phase Forward, Siow Bee Seu, Director of Clinical Operations for APAC at Indero, shares her perspective on the evolving clinical trial landscape across the APAC region. With nearly 2 decades of experience in clinical research, she offers valuable insights into the strategic importance of APAC in global trials. Drawing from her expertise in project operations, regulatory strategy, and team leadership, Siow discusses how clinical trial approaches must adapt to the unique contexts of individual countries while navigating the region’s complex regulatory environment. Her reflections provide a practical look at managing trials in one of the world’s most dynamic regions.